2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
productionglue (A TAIT Company)
Category
Event - Art Event
Country / Region
United States
Entrant Company
NBCUniversal
Category
Event - B2B Event
Country / Region
United States
Entrant Company
Soul Vision Films
Category
Experiential & Immersive - 360 Video
Country / Region
Australia
Entrant Company
Digidea Dijital Hizmetler
Category
Video - Health & Fitness
Country / Region
Turkey